Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach
Zhou, Shu-Feng, Pan, Shu-Ting, Zhou, Zhi-Wei, He, Zhixue, Zhang, Xueji, Yang, Tianxin, Yang, Yin-Xue, Qian, Chengyuan, Qiu, JiaxuanLanguage:
english
Journal:
Drug Design, Development and Therapy
DOI:
10.2147/DDDT.S76021
Date:
February, 2015
File:
PDF, 4.98 MB
english, 2015